The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Smagina I.V.

Otdelenie nevrologii kraevoĭ klinicheskoĭ bolnitsy, Barnaul;
kafedra nervnykh bolezneĭ s kursom nevrologii i refleksoterapii fakulteta povysheniia kvalifikatsii i PPS, Barnaul;
kafedra biokhimii i klinicheskoĭ laboratornoĭ diagnostiki Altaĭskogo gosudarstvennogo meditsinskogo universiteta, Barnaul;
Novosibirskiĭ gosudarstvennyĭ universitet, Novosibirsk

Elchaninova S.A.

Zolovkina A.G.

Ignatova Iu.N.

Kudriavtseva E.A.

Genetic risk factors for multiple sclerosis in the population of Altay

Authors:

Smagina I.V., Elchaninova S.A., Zolovkina A.G., Ignatova Iu.N., Kudriavtseva E.A.

More about the authors

Read: 1025 times


To cite this article:

Smagina IV, Elchaninova SA, Zolovkina AG, Ignatova IuN, Kudriavtseva EA. Genetic risk factors for multiple sclerosis in the population of Altay. S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(5):42‑45. (In Russ.)

Recommended articles:
Surgical treatment of seco­ndary trigeminal neuralgia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):203-209
Quality of life of patients with multiple scle­rosis in the Smolensk region. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):36-40
Hormonal contraception methods and multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):24-30
Epidemiology of multiple scle­rosis in the city of Novo­sibirsk. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):119-127
A clinical case of X-linked adre­noleukodystrophy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):102-107
Cognitive impairment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):67-73
Arti­ficial inte­lligence capa­bilities in multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):14-21

References:

  1. Boiko A.N., Favorova O.O. Rasseyannyi skleroz: molekulyarnye i kletochnye mekhanizmy. Molekulyarnaya biologiya 1995; 29: 4: 727
  2. Smagina I.V., Lichenko Yu.N., Fedyanin A.S., El'chaninova S.A. Epidemiologiya rasseyannogo skleroza v Altaiskom krae. Nevrol zhurn 2010; 1: 24-27.
  3. Favorova O.O., Kulakova O.G., Boiko A.N. Rasseyannyi skleroz kak poligennoe zabolevanie: sovremennoe sostoyanie problemy. Genetika 2010; 46: 3: 302-313.
  4. Shmidt T.E., Yakhno N.N. Rasseyannyi skleroz: rukovodstvo dlya vrachei. 2-e izd. M: MEDpress-inform 2010; 272.
  5. Benveniste E.N., Nguyen V.T., Wesemann D.R. Molecular regulation of CD40 gene expression in macrophages and microglia. Brain Behav. Immun 2004; 18: 7-12.
  6. Bomprezzi R., Kovanen P.E., Martin R. New approaches to investigating heterogeneity in complex traits. J Med Genet 2003; 40: 553-559.
  7. Drulovic J., Popadic D., Mesaros S. et al. Decreased frequency of the tumor necrosis factor alpha -308 allele in Serbian patients with multiple sclerosis. Eur Neurol 2003; 50: 1: 25-29.
  8. Duran I. et al. Immunological profile of patiemts with primary progressive multiple sclerosis: expression of adhesion molecules. Brain 1999; 122: 2297-2307.
  9. Favorova O.O., Favorov A.V., Boiko A.N. et al. Three allele combinations associated with Multiple Sclerosis. BMC Med l Genetics 2006; 63: 1-9.
  10. Forte G.I., Ragonese P., Salemi G. et al. Search for Genetic Factors Associated with Susceptibility to Multiple Sclerosis. Annals New York Academy of Sciences 2006; 1067: 264-269.
  11. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurol 1983; 33: 12: 1444-1452.
  12. Lucotte G., Bathelier C., Mercier G. TNF-α polymorphisms in multiple sclerosis: no association with -238 and - 308 promoter alleles, but the microsatellite allele a II is associated with the disease in French patients. Multple Sclerosis 2000; 6: 2: 78-80.
  13. Orozco G., Eyre S., Hinks A. et al. Association of CD40 with rheumatoid arthritis confirmed in a large UK case-control study. Ann Rheum Dis 2010; 69: 813-816.
  14. Polman C.H., Reingold S.C., Edan C. et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald. Ann Neurol 2005; 56: 840-864.
  15. Ristić S. et al. Tumor Necrosis Factor-α -308 gene polymorphism in Croatian and Slovenian multiple sclerosis patients. Eur Neurol 2007; 57: 203-207.
  16. Selmaj K., Raine C., Cannella B. et al. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 1997; 37: 949-954.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.